Skip to main content
. 2004 Jun 8;91(1):18–22. doi: 10.1038/sj.bjc.6601891

Table 2. Response to combination chemotherapy.

Response Total (N=30) Epi 30 mg m−2 (N=22) Epi 40 mg m−2 (N=8)
Complete response 1 (3%) 1 (5%) 0
Partial response 13 (43%) 9 (41%) 4 (50%)
Stable disease 13 (43%) 9 (41%) 4 (50%)
Progressive disease 3 (10%) 3 (14%) 0

Epi=epirubicin.